Skip to main content
TN

Toro Neurovascular

Toro Neurovascular develops proprietary catheter technologies designed for thrombectomy procedures in ischemic stroke treatment, enabling efficient navigation through complex cerebral vasculature. Their Toro 88 Superbore Catheter enhances clot removal capabilities, improving patient outcomes by empowering physicians to treat a higher volume of patients effectively.

Irvine, United StatesFounded 20236500+ followers
Updated 4 months ago

Funding

$3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Ischemic stroke, caused by blood clots obstructing arteries in the brain, is a leading cause of disability worldwide and poses a significant burden on healthcare systems. Current thrombectomy procedures can be limited by challenges in navigating the complex cerebral vasculature, potentially impacting the efficiency of clot removal and overall patient outcomes.

Solution

Toro Neurovascular develops advanced catheter technologies designed to improve the efficiency and effectiveness of thrombectomy procedures for ischemic stroke. Their Superbore Catheters are engineered to navigate challenging distal vasculature, enabling physicians to access and remove clots more effectively. The catheters' design aims to simplify the procedure, empowering physicians to treat a higher volume of patients and improve access to care globally. The company focuses on providing reliable tools that can enhance clot ingestion and improve patient outcomes in stroke treatment.

Target Audience

The primary target audience includes physicians, hospitals, and healthcare systems involved in stroke treatment, particularly those specializing in neurovascular procedures and thrombectomy.

Features

  • Superbore Catheter designed to track to the MCA over a microcatheter.
  • MicroFlex Technology for efficient tracking to the M1.
  • Distal Glide Zone for conforming in tortuosity.
  • Vessel-matched aspiration to empower complete clot ingestion.
  • Engineered for reliability, empowering physicians of all skill levels.
This profile is AI-generated and may contain inaccuracies.